The Biden administration said Friday it expects omicron to become the dominant strain of the coronavirus within weeks and predicted the fallout will divide into two paths, causing mild cases among vaccinated-and-boosted Americans while the unvaccinated confront a winter of misery and death.
Recipients of the Johnson & Johnson COVID-19 vaccine were more likely to experience a rare blood clotting issue than persons in the general population before the pandemic, according to a study published Monday by JAMA Internal Medicine.
Recipients of the Johnson & Johnson COVID-19 vaccine were more likely to experience a rare blood clotting issue than persons in the general population before the pandemic, according to a study published Monday by JAMA Internal Medicine.
Drugmaker Moderna said Tuesday it will make up to 110 million doses of its COVID-19 vaccine available to the African Union as the company faces pressure to reach beyond wealthier countries.